Endocrinology @Point of Care Podcasts

De: @Point of Care
Escúchala gratis

  • Resumen

  • Our @Point of Care Endocrinology Podcasts have healthcare experts discussing and providing information related to endocrinology diagnosis, treatment, management, and other important information.
    Copyright 2021 At Point of Care, LLC. All rights reserved.
    Más Menos
activate_primeday_promo_in_buybox_DT
Episodios
  • S1E6 - SGLT-2 Inhibitors Morning Commute: A Clinical Pathway for Action

    S1E6 - SGLT-2 Inhibitors Morning Commute: A Clinical Pathway for Action
    May 7 2021
    Visit http://morningcommutepodcast.com/SGLT2inhibitors6 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode, Dr. James Januzzi and Dr. Silvio Inzucchi discuss the surge in collaboration between primary care physicians, endocrinologists, and cardiologists and the groundswell of cardiometabolic clinics. They attribute this to cardiologists moving beyond the so-called glucocentric view and focusing on how diabetes therapies might help reduce cardiovascular risk as well. Drs. Januzzi and Inzucchi will also discuss the recent guidelines that now incorporate sodium-glucose cotransporter 2 (SGLT-2) inhibitors into clinical pathways.
    Más Menos
    24 m
  • S1E5 - SGLT-2 Inhibitors Morning Commute: The Heart Failure Connection

    S1E5 - SGLT-2 Inhibitors Morning Commute: The Heart Failure Connection
    May 7 2021

    Visit http://morningcommutepodcast.com/SGLT2inhibitors5 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode Dr. James Januzzi and Dr. Silvio Inzucchi discuss how sodium-glucose cotransporter 2 (SGLT-2) inhibitors evolved from treatments for type 2 diabetes mellitus (T2DM) to key treatments for patients with heart failure. Drs. Januzzi and Inzucchi look at the pivotal trials that thrust these treatments into the heart failure treatment limelight.
    Más Menos
    24 m
  • S1E4 - SGLT-2 Inhibitors Morning Commute: Widening Benefit

    S1E4 - SGLT-2 Inhibitors Morning Commute: Widening Benefit
    May 7 2021

    Visit http://morningcommutepodcast.com/SGLT2inhibitors4 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode Dr. James Januzzi and Dr. Silvio Inzucchi will discuss SGLT-2 inhibition in cardiovascular risk reduction by taking a look at some of the pivotal clinical trial data.
    Más Menos
    25 m
Hygiene & Healthy Living
Más Menos

Lo que los oyentes dicen sobre Endocrinology @Point of Care Podcasts

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles